Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Fertility drug choice may impact IUI success, large study suggests

NCT ID NCT03669276

First seen Jun 23, 2026 · Last updated Jun 23, 2026

Summary

This study reviewed 1251 intrauterine insemination (IUI) cycles at one hospital to see if the type of fertility drug used or the cause of infertility affected pregnancy rates. Participants were women aged 20-44 with normal ovulation and their partners with adequate sperm. The researchers looked at clinical pregnancy and live-birth rates, aiming to identify factors that lead to better outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU Amiens-Picardie

    Amiens, 80054, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

gonadotropins (recombinant FSH, urinary FSH, or hMG)

What this could lead to

If successful, this could help doctors choose the best ovarian stimulation drug for each couple, potentially improving IUI success rates.

What could go wrong

This is a retrospective review, not a controlled trial, so results may not prove cause and effect. Findings may not apply to all fertility clinics or patient groups.

Conditions

The condition(s) this trial relates to.

Infertility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.